News

  • Patients take legal action to save frozen embryos after admin error

    At least 15 fertility patients are taking legal action to prevent their frozen embryos being destroyed after administrative errors left them at risk of losing their chance to have children. The group includes people with cancer and fertility problems who froze gametes (eggs and sperm) or embryos to improve their chances of conceiving later on, [...]

  • Dame Lesley Regan vows to ‘revamp’ UK’s Women’s Health Strategy – “we’ve let women and girls down”

    The Women’s Health Ambassador for England, Dame Lesley Regan, has promised to overhaul the government’s 10-year strategy, as she revealed the scale and cost of the UK’s gender health gap three years on. Speaking at Women’s Health Week in London earlier this month, Regan revealed that Health Secretary Wes Streeting has tasked her with “revamping” [...]

  • AI identifies women at high risk of breast cancer

    AI technology can identify 42 per cent of breast cancers that develop between routine mammograms by flagging women at highest risk, researchers have found. The study analysed 134,217 screening mammograms using a deep learning model known as Mirai, which estimates breast cancer risk from imaging data, tumour features and breast density. Researchers from the University [...]

  • LiviWell raises US$3.3m for vaginal health device

    LiviWell has raised US$3.3m seed funding to advance FDA clearance and ready the launch of Livi, a post-intercourse device for vaginal microbiome balance. Livi is a medical-grade polyurethane foam device inserted with an applicator immediately after intercourse. It absorbs semen and other fluids in under 60 seconds, helping to maintain vaginal pH and support the [...]

  • Most midlife women with menopause symptoms don’t seek care, research finds

    More than 80 per cent of women with menopause symptoms do not seek medical help, despite the impact on daily life, according to new research. The study surveyed nearly 5,000 women aged 45 to 60 across four Mayo Clinic primary care sites, finding that more than three-quarters had experienced symptoms affecting work productivity and overall [...]

  • Roundup: first-of-its-kind partnership with NHS and period tracking app

    Femtech World explores the latest business developments in the world of women’s health. NHS platform Evaro partners with period tracking app Clue in UK-first integration Evaro, the NHS-licensed embedded healthcare platform, has announced a first-of-its-kind partnership with the period tracking app Clue. The partnership will provide seamless access to NHS-funded contraception directly through Clue's app. [...]

  • Morning-after pill now free across pharmacies in England

    The NHS has made the morning-after pill free at almost 10,000 pharmacies in England, ending postcode lottery access to emergency contraception. Women can now obtain the emergency pill without charge at their local pharmacy, removing the need to visit a GP or attend a sexual health clinic. Some pharmacies had previously charged up to £30 [...]

  • From SEO to GEO: How women’s health brands can get found in the age of AI

    By Martin Piria, senior machine learning engineer at Ema Search has changed. For years, Women's Health companies have invested in SEO, optimising their websites so Google would surface their content. But now, as consumers increasingly ask health questions directly to AI like ChatGPT, Perplexity, Ema, or Claude, a new frontier is emerging for brands that [...]

  • Propel Healthtech West Yorkshire launches programme to support healthtech innovators

    Propel Healthtech West Yorkshire is calling on innovators with healthtech solutions to apply for its accelerator programme. The programme is free for successful applicants and provides enhanced business support, regulatory guidance, NHS networking and scaled growth advice. The accelerator has recently been allocated £4.5m in funding from the West Yorkshire Mayor’s investment Zone. The funding [...]

  • FDA approves new menopause drug to treat hot flashes and night sweats

    The FDA has approved elinzanetant, a new non-hormonal treatment for menopause that reduces hot flushes and night sweats. Clinical trials in the US, Europe and Israel found the drug significantly reduced both the frequency and severity of hot flushes while improving women’s sleep and quality of life. The approval follows successful results from the double-blind [...]